Otros idiomas Pharming Group N.V.

Acciones

En tiempo real Euronext Amsterdam Otros sitios de cotización 10:58:46 19/06/2024			Varia. Cinco días.	Varia. 1 de enero.
0,758 ^EUR	-0,20 %		-1,37 %	-26,48 %

31/05	Pharming Group anuncia un retraso en la revisión de la UE de un fármaco contra las inmunodeficiencias raras	MT
30/05	Pharming Group N.V. proporciona información actualizada sobre la revisión reglamentaria en curso del leniolisib para el tratamiento de la apd en la Unión Europea	CI

Pharming N : Jefferies Healthcare Conference Presentation June 5 6, 2024	05/06
Pharming Group to participate in June investor conferences	03/06
Pharming Group Flags Delay in EU Review of Rare Immunodeficiency Drug	31/05
Tegenslag bij EMA resulteert in tijdverlies voor Pharming	31/05
Pharming N : Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union - Form 6-K	30/05
Europese goedkeuring voor leniolisib van Pharming loopt vertraging op	30/05
Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union	30/05
Pharming Group N.V. Provides Update on Ongoing Regulatory Review of Leniolisib for the Treatment of Apds in the European Union	30/05
Pharming N : Physical Settlement Notice 2029 Convertible Bonds	28/05
Pharming N : Publication of Voting Results of the AGM 2024	23/05
Pharming N : Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders	22/05
Pharming N : Presentation AGM 2024	21/05
Jaarvergadering Pharming akkoord met alle agendapunten	21/05
Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders	21/05
Pharming Group to participate in May investor conference	20/05
Beursagenda: Nederlandse bedrijven	20/05
Beursagenda: Nederlandse bedrijven	17/05
Pharming N : Presentatie - mei 2024	16/05
Pharming N : Corporate Presentation - May 2024	15/05
Pharming N : 1Q 2024 financial results - Analyst & Investor Call transcript	15/05

No hay resultados para esta búsqueda